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Introduction
Significant susceptibility of some drugs to degradation 
requires proper selection of conditions of chromatographic 
separation. During the optimization of chromatographic pro-
cedure, the following features should be taken into account: 
limitation of reagents, which can catalyze degradation of 
labile analytes, short run time and achievement of required 
validation parameters. Among all validation parameters, 
the most essential is achievement of selectivity [1]. The 
achievement of suitable selectivity is critical parameter dur-
ing method validation when the kind of degradation products 
depends on the affecting factors. Carbapenems doripenem 
(DOR), meropenem (MER) and tebipenem (TEB) were cho-
sen as model drugs, which exhibit a significant instability 
in aqueous solutions and in the solid state. Available studies 
report that in the case of abovementioned antibiotics, formed 
degradation products depend on the concentration of investi-
gated drug, pH of the solution, temperature and presence of 
acids and bases. It has been proved that different products as 
the result of carbapenem degradation were formed in solid 
state as well as in aqueous solutions [2]. The main degrada-
tion pathway of carbapenems degradation leads to the crack-
ing of β-lactam bond in a bicyclic-fused rings structure. 
Existing papers have been reported that most of the chro-
matographic procedures were based on columns filled with 
5 μm particles [2–7]. Application of columns with smaller 
particle sizes was reported for only a few β-lactam antibiot-
ics [8–10]. However, the benefits of such analytical methods 
can be significant, taking into account higher reduction of the 
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run time of analysis and shorter contact with reagents, which 
cause the hydrolytic degradation of investigated substances 
during sample preparation and chromatographic analysis [11, 
12]. Therefore, it is such an important study of transfer from 
HPLC procedure to UPLC separation in the case of labile 
drugs. The aim of our studies was to select the best analytical 
conditions for the determination of labile carbapenem ana-
logues, in the presence of their degradation products.
Experimental
Standards and Reagents
DORIBAX™ (Janssen-Cilag International NV, Beerse, Bel-
gium) containing doripenem monohydrate as an anhydrous 
basis form was used as doripenem standard. Meropenem 
(purity >98 %) was obtained from CHEMOS (Regenstauf, 
Germany). Tebipenem (purity >98 %) was supplied by 
Pharmachem International (Wuhan, China). All other chem-
icals and solvents were obtained from Merck KGaA (Darm-
stadt, Germany) and were of analytical grade. High-quality 
pure water was prepared using a Millipore Exil SA 67120 
purification system (Millipore, Molsheim, France).
Instrumentation
The Dionex Ultimate 3000 analytical system consisted 
of a quaternary pump, an autosampler, a column oven 
and a diode array detector. Three Kinetex, C18, 100A, 
100 × 2.1 mm columns (Phenomenex, Torrance, USA) 
with different particle sizes (1.7, 2.6 and 5 µm) were tested. 
The mobile phase composed of acetonitrile and 12 mmol 
L−1 ammonium acetate in different ratios (Table 1). The 
flow rate of the mobile phase was 1.0 mL min−1. The wave-
length of the DAD detector was set at 298 nm. Separation 
was performed at 30 °C.
Procedure for Forced Degradation Study of API’s
Degradation in Aqueous Solutions
The degradation of analysed API’s (active pharmaceutical 
ingredient) in aqueous solutions was studied at 293 K in 
sodium hydroxide solution (0.3 mol L−1) and at 353 K in 
hydrochloric acid (0.3 mol L−1). The ionic strength of all 
solutions was adjusted to 0.5 mol L−1 with a solution of 
sodium chloride (4.0 mol L−1). Degradation was initiated 
by dissolving an accurately weighed 5.0 mg of analysed 
drug in 10.0 mL of the solution equilibrated to the desired 
temperature in stoppered flasks. At specified times, sam-
ples of the reaction solutions were neutralised and instantly 
cooled with a mixture of ice and water.
Degradation in Solid State
5.0 mg samples of analysed API’s were weighed into 5 mL 
glass vials. To evaluate the influence of temperature and 
humidity, the samples were placed in a desiccator contain-
ing saturated solution of sodium chloride (RH ~76.4 %) 
that was in incubators (Wamed, Warsaw, Poland) set to 
temperature 333 K. At specified time intervals, determined 
by the rate of degradation, the vials were removed, cooled 
to room temperature and their contents were dissolved in 
water. The so-obtained solutions were quantitatively trans-
ferred into measuring flasks and diluted with the same sol-
vent to 10.0 mL.
Results and Discussion
Chromatographic studies of β-lactam analogues are com-
plicated due to their significant susceptibility to degrada-
tion, as well as possibility of catalytic effect of their degra-
dation products to stability of parent compound.
In this article, different analytical procedures based 
on core shell C18 stationary phases with various parti-
cle sizes were evaluated. The fully porous C18 columns 
filled with 5 µm particles allowed the determination of 
analysed carbapenems in about 15 min [2–8]. Employ-
ment of core shell 5 µm particles technology leaded 
to essential reduction of retention times (tR) (Table 1). 
The determination of carbapenem analogues based on 
the core shell C-18 columns with particles 2.6 µm did 
not give significant benefits in regard to the reduction 
of retention times. However, this application produces 
higher pressures. In the case of determination of carbap-
enems analogues using core shell C-18 columns with 
1.7 µm particles, the retention times represented similar 
values as in separation based on stationary phase with 
greater particles, but simultaneously flow rate was twice 
less (Table 1). This approach is compromised between 
reduction of consumption organic solvents and high 
pressure which appears in developed method with 5 µm 
particles.
Validation of analytical methods for the determination 
of carbapenems using C-18 stationary phase with differ-
ent particle sizes was conducted in regarding to linear-
ity, precision, accuracy, LOD and LOQ. The significant 
reduce tR of carbapenem after application of core shell 
columns did not influence on separation of main peaks 
(meropenem, doripenem and tebipenem) from degra-
dation products. Suitable symmetry of peaks of main 
substances as well as related products was unchanged. 
Order of time retentions for all analytes was the same 
as in the separation based on fully porous station-
ary phases. For all the analogues of carbapenems, the 
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linear relationships between concentration of analytes 
and response of detector were achieved. The widest 
ranges of linear response were obtained when carbapen-
ems were determined with usage of core shell columns 
with 5 µm particles. Those determinations were char-
acterised by the most satisfied regression coefficients. 
Table 2 shows linear response function of concentration 
over the range 0.5–3.0 µg and regression coefficients 
(r) were >0.995 for all the carbapenems. Similar results 
were obtained for precision studies. It was shown that 
the lowest values of intra-day and inter-day precision 
were calculated in the cases of determination of DOR, 





HPLC [7] HPLC UHPLC UHPLC
Column type LiChrospher C-18; 
5 µm; fully porous; 
250 × 4.6 mm
Kinetex C 18; 5 µm; core shell; 
100 × 2.1 mm
Kinetex C 18; 2.6 µm; core 
shell; 100 × 2.1 mm
Kinetex C 18; 1.7 µm; core 
shell; 100 × 2.1 mm
Mobile phase 12 mM ammonium 
acetate–acetonitrile 
(96:4 v/v)
12 mM ammonium acetate–
acetonitrile (96:4 v/v)
12 mM ammonium acetate–
acetonitrile (96:4 v/v)
12 mM ammonium acetate–
acetonitrile (90:10 v/v)
Flow rate 1.2 mL min−1 1.0 mL min−1 1.0 mL min−1 0.5 mL min−1
Detection wavelength 298 nm 298 nm 298 nm 298 nm
tR 6.2 min 0.823 min 0.869 min 0.666 min
Asymmetry 0.97 1.03 1.38
Pressure 244 bar 822 bar 710 bar





HPLC [4] HPLC UHPLC UHPLC
Column type LiChrospher C-18; 5 µm; fully 
porous; 250 × 4.6 mm
Kinetex C 18; 5 µm; core 
shell; 100 × 2.1 mm
Kinetex C 18; 2.6 µm; core 
shell; 100 × 2.1 mm
Kinetex C 18; 1.7 µm; core 
shell; 100 × 2.1 mm
Mobile phase 12 mM ammonium acetate–
acetonitrile (92:8 v/v)
12 mM ammonium acetate–
acetonitrile (93:7 v/v)
12 mM ammonium acetate–
acetonitrile (93:7 v/v)
12 mM ammonium acetate–
acetonitrile (90:10 v/v)
Flow rate 1.2 mL min−1 1.0 mL min−1 1.0 mL min−1 0.5 mL min−1
Detection wavelength 298 nm 298 nm 298 nm 298 nm
tR 4.32 min 0.683 min 0.79 min 0.584 min
Asymmetry 0.92 1.12 1.39
Pressure 273 bar 825 bar 710 bar





HPLC [3] HPLC UHPLC UHPLC
Column type LiChrospher C-18; 5 µm; fully 
porous; 250 × 4.6 mm
Kinetex C 18; 5 µm; core 
shell; 100 × 2.1 mm
Kinetex C 18; 2.6 µm; core 
shell; 100 × 2.1 mm
Kinetex C 18; 1.7 µm; core 
shell; 100 × 2.1 mm
Mobile phase 12 mM ammonium acetate–
acetonitrile (96:4 v/v)
12 mM ammonium acetate–
acetonitrile (93:7 v/v)
12 mM ammonium acetate–
acetonitrile (90:10 v/v)
12 mM ammonium acetate–
acetonitrile (90:10 v/v)
Flow rate 1.2 mL min−1 1.0 mL min−1 1.0 mL min−1 0.5 mL min−1
Detection wavelength 298 nm 298 nm 298 nm 298 nm
tR 12.32 min 0.87 min 0.533 min 1.16 min
Asymmetry 1.14 1.12 0.76
Pressure 287 bar 825 bar 682 bar
Temperature 30 °C 30 °C 30 °C
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MER and TEB using C-18 column filled with 5 µm par-
ticles. Method repeatability data as accuracy are summa-
rised in Fig. 1.
Decreasing particle sizes from 2.6 to 1.7 µm in core 
shell columns did not significantly influence RDS % val-
ues characterising intra-day and inter-day precision. The 
accuracy of determination of carbapenem analogues was 
established at three concentration levels: 80,100 and 120 % 
of label claim. However, significant differences between 
accuracy of determinations of carbapenems analogues were 
not observed (Fig. 2a–c). The lowest values of LOD and 
LOQ for carbapenems were obtained when their determi-
nations were conducted on core shell column filed with 
5 µm particles.
Table 2  Linear range, 
regression data, and LODs and 
LOQs for analysis of selected 
carbapenems
Column type  
(µm)
Regression equation R2 Linear  
range (µg)
LOD (µg) LOQ (µg)
Doripenem
 1.7 y = 39.330x + 7.833 0.9954 0.50–3.00 0.12 0.34
 2.6 y = 20.285x 0.9997 0.25–3.00 0.03 0.09
 5.0 y = 22.324x 0.9999 0.05–3.00 0.01 0.03
Meropenem
 1.7 y = 36.863x + 11.004 0.9928 0.50–3.00 0.14 0.43
 2.6 y = 19.609x 0.9997 0.25–3.00 0.03 0.09
 5.0 y = 22.314x 0.9999 0.05–3.00 0.01 0.02
Tebipenem
 1.7 y = 48.147x 0.9999 0.50–3.00 0.01 0.03
 2.6 y = 28.856x 0.9999 0.05–3.00 0.01 0.02
 5.0 y = 22.518x 0.9999 0.05–3.00 0.01 0.03
Fig. 1  Inter-day (a–c) and intra-day (d–f) precision of determination of carbapenem analogues at 80 % (a, d), 100 % (b, e) and 120 % (c, f) lev-
els of initial concentration
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Conclusions
In the presented study, the influence of the particle size of 
core shell stationary phase on parameters of labile drugs 
determination was examined. An achievement of the most 
satisfactory validation parameters was possible when the 
doripenem, meropenem and tebipenem were determined 
using core shell C-18, 5 µm stationary phases. The separa-
tion of carbapenems based on core shell C-18, 5 µm sta-
tionary phases is valuable due to short time of analysis, 
long vitality of column and possibility to work on classical 
HPLC systems (dedicated for max pressure 400 bars).
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